ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc (DNA)

10.83
0.63
(6.18%)
마감 18 1월 6:00AM
10.6106
-0.2194
(-2.03%)
시간외 거래: 9:17AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
10.6106
매수가
-
매도가
-
거래량
1,194,622
9.99 일간 변동폭 10.93
5.26 52주 범위 64.40
market_cap
전일 종가
10.20
개장가
10.31
최근 거래 시간
1
@
10.61
마지막 거래 시간
재정 규모
US$ 12,544,750
VWAP
10.501
평균 볼륨(3m)
1,311,671
발행 주식
57,478,905
배당수익률
-
주가수익률
-0.70
주당순이익(EPS)
-15.53
매출
251.46M
순이익
-892.87M

Ginkgo Bioworks Holdings Inc 정보

Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.

섹터
Biological Pds,ex Diagnstics
산업
Blank Checks
웹사이트
본부
Wilmington, Delaware, USA
설립됨
2021
Ginkgo Bioworks Holdings Inc is listed in the Biological Pds,ex Diagnstics sector of the 뉴욕 증권거래소 with ticker DNA. The last closing price for Ginkgo Bioworks was US$10.20. Over the last year, Ginkgo Bioworks shares have traded in a share price range of US$ 5.26 to US$ 64.40.

Ginkgo Bioworks currently has 57,478,905 shares in issue. The market capitalisation of Ginkgo Bioworks is US$586.28 million. Ginkgo Bioworks has a price to earnings ratio (PE ratio) of -0.70.

Ginkgo Bioworks (DNA) 옵션 플로우 요약

전체 흐름

강세

순 프리미엄

1M

Calls / Puts

900.00%

매수 / 매도

300.00%

OTM / ITM

11.11%

Sweeps 비율

0.00%

DNA 최신 뉴스

Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors

Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors PR Newswire BOSTON, Jan. 13, 2025 Collaboration...

Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire BOSTON, Jan. 9, 2025 BOSTON, Jan. 9, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA...

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program PR...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.1694-1.5714285714310.7810.8458.4412765189.29055067CS
42.150625.42080378258.4612.758.4141228210.06030963CS
122.620632.79849812277.9912.756.0113116719.13242126CS
26-3.8614-26.681868435614.47216.3925.26957884811.47027856CS
52-37.7894-78.077272727348.464.45.262478800627.07036396CS
156-213.7894-95.2715686275224.4255.25.262280220069.65732366CS
260-438.9894-97.6399911032449.6634.565.262142625284.98477101CS

DNA - Frequently Asked Questions (FAQ)

What is the current Ginkgo Bioworks share price?
The current share price of Ginkgo Bioworks is US$ 10.6106
How many Ginkgo Bioworks shares are in issue?
Ginkgo Bioworks has 57,478,905 shares in issue
What is the market cap of Ginkgo Bioworks?
The market capitalisation of Ginkgo Bioworks is USD 586.28M
What is the 1 year trading range for Ginkgo Bioworks share price?
Ginkgo Bioworks has traded in the range of US$ 5.26 to US$ 64.40 during the past year
What is the PE ratio of Ginkgo Bioworks?
The price to earnings ratio of Ginkgo Bioworks is -0.7
What is the cash to sales ratio of Ginkgo Bioworks?
The cash to sales ratio of Ginkgo Bioworks is 2.48
What is the reporting currency for Ginkgo Bioworks?
Ginkgo Bioworks reports financial results in USD
What is the latest annual turnover for Ginkgo Bioworks?
The latest annual turnover of Ginkgo Bioworks is USD 251.46M
What is the latest annual profit for Ginkgo Bioworks?
The latest annual profit of Ginkgo Bioworks is USD -892.87M
What is the registered address of Ginkgo Bioworks?
The registered address for Ginkgo Bioworks is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Ginkgo Bioworks website address?
The website address for Ginkgo Bioworks is www.ginkgobioworks.com
Which industry sector does Ginkgo Bioworks operate in?
Ginkgo Bioworks operates in the BLANK CHECKS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ARLAmerican Realty Investors Inc
US$ 15.93
(15.02%)
10.76k
RBOTVicarious Surgical Inc
US$ 16.382
(14.88%)
52.57k
AUNAAuna SA
US$ 8.45
(14.81%)
233.16k
MYTEMYT Netherlands Parent BV
US$ 9.45
(12.23%)
354.61k
BKSYBlackSky Technology Inc
US$ 11.71
(12.06%)
1.7M
SESSES AI Corporation
US$ 0.9369
(-9.91%)
51.58M
DMDesktop Metal Inc
US$ 2.19
(-9.88%)
547.32k
JKSJinkosolar Holdings Co Ltd
US$ 21.23
(-9.81%)
1.55M
BODIBeachbody Company Inc
US$ 6.60
(-9.59%)
19.82k
QBTSD Wave Quantum Inc
US$ 5.275
(-9.21%)
76.53M
QBTSD Wave Quantum Inc
US$ 5.275
(-9.21%)
76.53M
FFord Motor Company
US$ 10.18
(1.70%)
60.8M
BBDBanco Bradesco SA
US$ 1.96
(-1.01%)
59.92M
VALEVale SA
US$ 8.94
(1.94%)
59.4M
SESSES AI Corporation
US$ 0.9369
(-9.91%)
51.58M

DNA Discussion

게시물 보기
ItsMyOption ItsMyOption 5 일 전
DNA just hit over sold area $8.70 that is .22 before the 1:40 R/S should go back up $11.00 soon
👍️0
Monksdream Monksdream 4 주 전
DNA under $10
👍️0
Monksdream Monksdream 4 주 전
DNA, 10 day hourly
👍️ 1
PonkenPlonken PonkenPlonken 4 주 전
cheap
👍️0
Monksdream Monksdream 3 월 전
DNA under $10
👍️0
Monksdream Monksdream 4 월 전
DNA 10 day hourly post reverse split
👍️0
hwang_jini hwang_jini 4 월 전
Cascade (Gates) top holder
👍️0
Monksdream Monksdream 4 월 전
DNA new. 52 w eek low
👍️0
Monksdream Monksdream 4 월 전
DNA new 52/week low
👍️0
Monksdream Monksdream 5 월 전
DNA new 52 week low
👍️0
Monksdream Monksdream 5 월 전
DNA new 52 week low
👍️0
ItsMyOption ItsMyOption 5 월 전
even after 1:40 R/S DNA still has too many shares outstanding and corporate insiders have poorly mismanaged the company.
Ginkgo Bioworks needs complete restructure and less corporate greed. Some of their founders sell shares daily as they where gifted too many.
I stopped buying long ago and waiting to see if management can get their act together - they all deserve a pay cut!
👍️ 1
Monksdream Monksdream 5 월 전
DNA new 52 low
👍️0
Dingbatt Dingbatt 5 월 전
Interesting stock bought a few for tracking
To see what the crawdads do
👍️0
ItsMyOption ItsMyOption 5 월 전
poor management as they falsely pumped this stock now passing R/S effective Aug. 20
They also know they committed fraud and had to pass = 2. Officer Exculpation Proposal

Item 2 was to approve Article VIII of the Company’s Amended and Restated Certificate of Incorporation to permit officer exculpation (the “Officer Exculpation Proposal”), designated to be voted upon by the holders of Class A common stock and Class B common stock, voting together as a single class. The results of the vote were as follows:

exculpation
noun
a defense of some offensive behavior or some failure to keep a promise etc.
his transparent self-justification was unacceptable
the act of freeing from guilt or blame
👍️0
hwang_jini hwang_jini 6 월 전
bio scam….

https://www.prnewswire.com/news-releases/ginkgo-bioworks-to-hold-special-meeting-of-shareholders-302210173.html
👍️0
Acme Investments Acme Investments 7 월 전
Sometimes I wonder if big names get kickbacks in exchange for their names being used??
👍️0
Acme Investments Acme Investments 7 월 전
Cathy led her sheep 🐑 to slaughter!! Worst performing IPO I've ever seen!!
👍️ 1
Acme Investments Acme Investments 7 월 전
😂😂😂😂😂😂😂
👍️0
trade2brich trade2brich 7 월 전
ARK dumped all holdings. I am out. Cut my losses.
👍️0
Monksdream Monksdream 7 월 전
It will reverse split because there is no choice
👍️0
JohnnyBlaze JohnnyBlaze 7 월 전
Average down or cut losses?
👍️0
Monksdream Monksdream 7 월 전
DNA new 52 week low
👍️0
Acme Investments Acme Investments 7 월 전
Timber!!
👍️0
JohnnyBlaze JohnnyBlaze 7 월 전
Bought a few
👍️0
Acme Investments Acme Investments 7 월 전
R/S will be announced without warning!! Proceed with caution!!
👍️ 1
ItsMyOption ItsMyOption 7 월 전
Yes, new low and very unhappy with DNA management. They were too slow to start restructuring and they still have one of the founders selling stock daily - what does he know?
👍️0
Monksdream Monksdream 7 월 전
DNA new 52 week low
👍️0
Stump Jumper Stump Jumper 7 월 전
I appreciate the response and opinion. I would like to think we would get a small bounce upward from here before a possible RS....
👍️0
philaya philaya 8 월 전
Got in low...
Bounce ready.
👍️0
ItsMyOption ItsMyOption 8 월 전
I feel we are close to bottom possible around.50 as lots of shorts took this down fast. We know DNA is in restructuring mode, which they should have done a long time ago. We still have one of their founders selling shares daily which should be in their ethic guidance as he most likely has inside info on R/S soon.

Long term I am positive but unhappy with management.
👍️0
Stump Jumper Stump Jumper 8 월 전
Is this the bottom?
👍️0
Acme Investments Acme Investments 8 월 전
Acknowledge Me!! Lol 😂
👍️0
wiredawg wiredawg 8 월 전
Yep, yet another SPAC born public company that's in the toilet, I fore see a reverse announcement coming very soon, given they've received a listing standard Notice form the NYSE...
👍️0
Monksdream Monksdream 8 월 전
DNA new 52 week low
👍️0
Acme Investments Acme Investments 8 월 전
I'll take that as a no!! Lol 😂 The Cathy curse continues!!
👍️0
Acme Investments Acme Investments 8 월 전
Still happy??
👍️0
ItsMyOption ItsMyOption 8 월 전
Why DNA will keep going down is all the insider selling from page 43 of last finacials: Austin has been selling shares daily so it is founders driving the price below SEC requirements of min of $1.00
Ginkgo’s Founders currently own nearly 20% of the outstanding shares of Ginkgo, the vast majority of which are in Class B shares
? Class B shares are not freely tradable (must be converted to Class A) and are often not shown on automated data services
? As such, these aggregation services (such as Bloomberg or Yahoo) can be unhelpful in determining actual holdings of certain investors, including
our Founders, who may hold different classes of shares which may not be included

Founder sales through April 29, 2024 relative to total holdings(1)
Mandatory Sell-to-Cover(2) 10b5-1 plan
Shares sold
(in millions) % of holdings
Shares sold
(in millions) % of holdings
Jason (CEO) 12.3 11.3% 10.4 9.6%
Reshma (COO) 12.3 11.4% 1.9 1.8%
Barry (CTO) 12.3 11.2% 1.9 1.7%
Austin 12.3 11.3% 0.9 0.8
👍️0
Acme Investments Acme Investments 8 월 전
Hope you took profits!! They just wanted to burn the shorts!!
👍️0
Acme Investments Acme Investments 8 월 전
That's a lot of risk for 30%......Eventually you'll get snake eyes!!
👍️0
trade2brich trade2brich 8 월 전
Bought at .70….up 30%
👍️0
Acme Investments Acme Investments 8 월 전
Don't know if you noticed but Cathy has lost her MOJO and her investors a lot of money!! Proceed with caution ⚠!!
👍️0
trade2brich trade2brich 8 월 전
ARK bought 12 million shares on Friday
👍️0
Acme Investments Acme Investments 8 월 전
Ark is like the cattle whisperer!! Slaughter awaits!!
👍️0
Monksdream Monksdream 9 월 전
DNA new 52 week low
👍️0
Monksdream Monksdream 9 월 전
Aren’t you the smart one

👍️0
trade2brich trade2brich 9 월 전
I did not I keep buying
👍️0
Monksdream Monksdream 9 월 전
No, you buy
New 52 week lo
👍️0
trade2brich trade2brich 9 월 전
Buy
👍️0
Monksdream Monksdream 9 월 전
DNA new 52 lo

👍️0

최근 히스토리

Delayed Upgrade Clock